Department of Cardiology, Hospital Universitario Arnau de Vilanova, Institut de Recerca Biomèdica de Lleida (IRBLleida), Lleida, Spain.
Department of Cardiology, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain; Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Int J Cardiol. 2023 Feb 15;373:1-6. doi: 10.1016/j.ijcard.2022.11.033. Epub 2022 Nov 23.
Some patients with spontaneous coronary artery dissection (SCAD) present as ST-segment-elevation myocardial infarction (STEMI). This study evaluates the characteristics, management and outcomes of SCAD patients presenting as STEMI compared to non-ST-segment elevation myocardial infarction (NSTEMI).
We analysed data from consecutive patients included in the prospective Spanish Registry on SCAD. All coronary angiograms were centrally reviewed. All adverse events were adjudicated by an independent Clinical Events Committee.
Between June 2015 to December 2020, 389 patients were included. Forty-two percent presented with STEMI and 56% with NSTEMI. STEMI patients showed a worse distal flow (TIMI flow 0-1 38% vs 19%, p < 0.001) and more severe (% diameter stenosis 85 ± 18 vs 75 ± 21, p < 0.001) and longer (42 ± 23 mm vs 35 ± 24 mm, p = 0.006) lesions. Patients with STEMI were more frequently treated with percutaneous coronary intervention (PCI) (31% vs 16%, p < 0.001) and developed more frequently left ventricular systolic dysfunction (21% vs 8%, p < 0.001). No differences were found in combined major adverse events during admission (7% vs 5%, p = 0.463), but in-hospital reinfarctions (5% vs 1.4%, p = 0.039) and cardiogenic shock (2.6% vs 0%, p = 0.019) were more frequently seen in the STEMI group. At late follow-up (median 29 months) no differences were found in the incidence of major adverse cardiac and cerebrovascular events (13% vs 13%, p-value = 0.882) between groups.
Patients with SCAD and STEMI had a worse angiographic profile and were more frequently referred to PCI compared to NSTEMI patients. Despite these disparities, both short and long-term prognosis were similar in STEMI and NSTEMI SCAD patients.
一些自发性冠状动脉夹层(SCAD)患者表现为 ST 段抬高型心肌梗死(STEMI)。本研究评估了与非 ST 段抬高型心肌梗死(NSTEMI)相比,以 STEMI 表现的 SCAD 患者的特征、治疗和结局。
我们分析了连续纳入前瞻性西班牙 SCAD 注册研究的患者数据。所有冠状动脉造影均由中心审查。所有不良事件均由独立临床事件委员会裁定。
2015 年 6 月至 2020 年 12 月,共纳入 389 例患者。42%的患者表现为 STEMI,56%的患者表现为 NSTEMI。STEMI 患者的远端血流较差(TIMI 血流 0-1 级 38% vs 19%,p<0.001),狭窄程度更严重(%直径狭窄 85±18% vs 75±21%,p<0.001),病变长度更长(42±23mm vs 35±24mm,p=0.006)。STEMI 患者更常接受经皮冠状动脉介入治疗(PCI)(31% vs 16%,p<0.001),更常发生左心室收缩功能障碍(21% vs 8%,p<0.001)。入院期间主要不良事件综合发生率无差异(7% vs 5%,p=0.463),但 STEMI 组住院期间再梗死(5% vs 1.4%,p=0.039)和心源性休克(2.6% vs 0%,p=0.019)更为常见。在晚期随访(中位数 29 个月)时,STEMI 和 NSTEMI SCAD 患者之间主要不良心脑血管事件的发生率无差异(13% vs 13%,p 值=0.882)。
与 NSTEMI 患者相比,以 STEMI 表现的 SCAD 患者的血管造影特征更差,更常接受 PCI 治疗。尽管存在这些差异,但 STEMI 和 NSTEMI SCAD 患者的短期和长期预后相似。